Our vision is to revolutionize the treatment of vision disorders through non-surgical, globally disruptive therapies. We are dedicated to developing a novel corneal remodeling therapy for patients with ectatic disorders like keratoconus, offering a safer and more effective alternative to traditional...See more
Headquarters:
New Zealand
Company Type:
SME
Company size:
1-10 Employees
Address:
171 HOBSON STREET; AUCKLAND, 1010, NZ
LOW
spending power
